Smartkarma AI, Smartkarma

αSK

Smartkarma AI

Smartkarma

Smartkarma unites the fragmented investment industry, connecting institutional investors, independent research providers, and corporates within a single network.

Research Reinvented

Equity Bottom-Up

<ul>
  <li>
<a href="https://smartkarma.com/entities/amesite-inc">Amesite</a> has strategically pivoted from a broad e-learning platform to a specialized AI-driven solutions provider for the healthcare sector, with its flagship product, NurseMagic™, at the forefront. This application is designed to significantly reduce the time healthcare professionals spend on documentation.</li>
  <li>The company is in its early growth stage, characterized by recent revenue increases driven by the adoption of NurseMagic™. However, <a href="https://smartkarma.com/entities/amesite-inc">Amesite</a> is not yet profitable and has a history of operating losses, relying on capital raises to fund its operations.</li>
  <li>The successful scaling of NurseMagic™ and the ability to achieve profitability are the key determinants of <a href="https://smartkarma.com/entities/amesite-inc">Amesite</a>'s future success. The company's performance is closely tied to its ability to penetrate the healthcare market and compete with both established and emerging players in the AI-powered healthcare solutions space.</li>
</ul><p><em>This content is AI-generated and displayed for general informational purposes only. Please verify independently before use.</em></p>


  
Amesite has strategically pivoted from a broad e-learning platform to a specialized AI-driven solutions provider for the healthcare sector, with its flagship product, NurseMagic™, at the forefront. This application is designed to significantly reduce the time healthcare professionals spend on documentation.
  The company is in its early growth stage, characterized by recent revenue increases driven by the adoption of NurseMagic™. However, Amesite is not yet profitable and has a history of operating losses, relying on capital raises to fund its operations.
  The successful scaling of NurseMagic™ and the ability to achieve profitability are the key determinants of Amesite's future success. The company's performance is closely tied to its ability to penetrate the healthcare market and compete with both established and emerging players in the AI-powered healthcare solutions space.
This content is AI-generated and displayed for general informational purposes only. Please verify independently before use.

Independent research on the U.S. markets, Baptista Research

Baptista Research

Independent research on the U.S. markets

Baptista Research is an independent financial research house focused on the U.S. markets. We provide equity research as well as credit research reports on the top-listed U.S. companies with most of our focus on technology, consumer goods and services, automobiles, industrials, oil and gas, pharma, and healthcare. Our research has served more than 3000 institutional investors including mutual funds, hedge funds, banks, family offices, and various buy-side firms. We operate a research subscription service where institutions, as well as retail investors, can have priority access to all our research. We also have a wide distribution of our research reports across some of the top global financial platforms. Apart from equity research and credit research, we also provide advisory services with respect to mergers & acquisitions (M&A), private equity/ venture capital fundraising, valuation reports, and investment management services for corporates.
Baptista Research is owned and managed by Ishan Majumdar, an ex-Venture Capitalist/ Investment Banker, a Chartered Accountant, and a Masters’ degree holder in Management from HEC Paris. Ishan has nearly a decade of experience in Mergers and Acquisitions, Leveraged Buyouts (LBOs), Venture Capital Investing, Corporate Strategy, and Valuation in front-office roles at the likes of BNP Paribas CIB, Credit Agricole CIB, Groupe Danone, and TIW Private Equity. He has worked on and closed multiple acquisition deals, leveraged buyouts, and start-up investment transactions.

Equity Capital Markets

<ul>
<li>This is our first report on Amesite and we look to provide a detailed account of the various drivers that will be responsible for the company’s growth in the coming years.</li>
<li>This presents an interesting investment opportunity for investors to be a part of a relatively cheap and emerging ed-tech play.</li>
<li>Overall, we are extremely bullish on Amesite and we believe that the company is an excellent investment bet at current levels.</li>
</ul>


This is our first report on Amesite and we look to provide a detailed account of the various drivers that will be responsible for the company’s growth in the coming years.
This presents an interesting investment opportunity for investors to be a part of a relatively cheap and emerging ed-tech play.
Overall, we are extremely bullish on Amesite and we believe that the company is an excellent investment bet at current levels.


United States

Amesite Inc. operates as a development stage artificial intelligence software company. The Company offers cloud-based platform for colleges and universities to improve the learner experiences and outcomes in courses and programs. Amesite serves customers in the United States.

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Amesite (AMST US)

Primer: Amesite (AMST US) - Oct 2025

Amesite has strategically pivoted from a broad e-learning platform to a specialized AI-driven solutions provider for the healthcare sector,...

αSK

Amesite Inc. - Investment Thesis

This is our first report on Amesite and we look to provide a detailed account of the various drivers that will be responsible for the company’s...

Baptista Research

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)